Fiche centre
Baylor University Medical Center
Dallas — United States
Essais liés4clinical trials
VilleDallaslocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT04141605
Essais cliniques associés
4| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| SherpaPak Cardiac Transport System | Insuffisance cardiaque | À vérifier | NCT04141605 | GUARDIAN — Global Utilization And Registry Database for Improved heArt preservatioN | ENROLLING_BY_INVITATION |
| Biopsy Procedure | SEP | Phase 2 | NCT02143414 | Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia | ACTIVE_NOT_RECRUITING |
| Elranatamab | Cancer | Phase 3 | NCT06152575 | MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide) | RECRUITING |
| H.P. Acthar Gel | Migraine | Phase 2 | NCT01813591 | A Two-Arm Study Evaluation H.P. Acthar Injection Gel in Treatment of Chronic Migraines | COMPLETED |